How to prescribe dapoxetine (Priligy®) for premature ejaculation

被引：0
作者：
Rebibo, J. D. [1 ]
机构：
[1] CHU Rouen, Serv Urol, 1 Rue Germont, F-76081 Rouen, France
来源：
PROGRES EN UROLOGIE | 2017年 / 27卷 / 02期
关键词：
Premature ejaculation; Erectile dysfunction; Dapoxetine; GUIDELINES;
D O I：
10.1016/j.fpurol.2017.04.001
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Premature ejaculation (PE) is the most frequent male sexual dysfunction, it affects about 20-24% of men. Dapoxetine is the first treatment approved in France. Its interest in the management of premature ejaculation is proven and appears to be improved with the association of cognitive behavioral therapy. The association improves the duration of sexual intercourse and a gradual decrease in the number of tablets needed. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：F36 / F37
页数：2
相关论文
共 50 条
[21]   Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation [J].
Andersson, KE ;
Mulhall, JP ;
Wyllie, MG .
BJU INTERNATIONAL, 2006, 97 (02) :311-315
[22]   The role of tyrosine hydroxylase within dapoxetine-assisted therapy against premature ejaculation [J].
Liu, Xi ;
Zhu, Tianle ;
Gao, Pan ;
Gao, Jingjing ;
Gao, Rui ;
Jiang, Hui ;
Zhang, Xiansheng .
MOLECULAR BIOLOGY REPORTS, 2023, 50 (04) :3515-3523
[23]   An Internally Validated Nomogram for Predicting the Likelihood of Improvement of Clinical Global Impression in Patients With Lifelong Premature Ejaculation Treated With Dapoxetine [J].
Hou, Guangdong ;
Gao, Ming ;
Zhang, Lei ;
Dun, Xinlong ;
Zheng, Yu ;
Wang, Fuli ;
Yan, Fei ;
Zheng, Wanxiang ;
Yin, Chuanmin ;
Yuan, Jiarui ;
Zhang, Geng ;
Meng, Ping ;
Jannini, Emmanuele A. ;
Yuan, Jianlin .
JOURNAL OF SEXUAL MEDICINE, 2020, 17 (12) :2341-2350
[24]   A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation [J].
Pastore, A. L. ;
Palleschi, G. ;
Leto, A. ;
Pacini, L. ;
Iori, F. ;
Leonardo, C. ;
Carbone, A. .
INTERNATIONAL JOURNAL OF ANDROLOGY, 2012, 35 (04) :528-533
[25]   Assessing satisfaction in men with premature ejaculation after dapoxetine treatment in real-world practice [J].
Jiann, B. -P. ;
Huang, Y. -J. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (11) :1326-1333
[26]   Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: A 2-Year Prospective Observational Study [J].
Park, Hyun Jun ;
Park, Nam Cheol ;
Kim, Tae Nam ;
Baek, Seung Ryong ;
Lee, Kyung Min ;
Choe, Sangmin .
SEXUAL MEDICINE, 2017, 5 (02) :E99-E105
[27]   Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine [J].
Shabsigh, Ridwan ;
Patrick, Donald L. ;
Rowland, David L. ;
Bull, Scott A. ;
Tesfaye, Fisseha ;
Rothman, Margaret .
BJU INTERNATIONAL, 2008, 102 (07) :824-828
[28]   Evaluation of dapoxetine treatment success in lifelong premature ejaculation patients with penile sympathetic skin response [J].
Kati, Bulent ;
Ay, Halil .
ANDROLOGIA, 2018, 50 (09)
[29]   Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review [J].
Russo, A. ;
Capogrosso, P. ;
Ventimiglia, E. ;
La Croce, G. ;
Boeri, L. ;
Montorsi, F. ;
Salonia, A. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (09) :723-733
[30]   Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors [J].
M J Dresser ;
D Desai ;
S Gidwani ;
A D Seftel ;
N B Modi .
International Journal of Impotence Research, 2006, 18 :104-110
12345